Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
21.69
+1.42 (7.01%)
At close: Dec 5, 2025, 4:00 PM EST
21.90
+0.21 (0.97%)
After-hours: Dec 5, 2025, 7:59 PM EST
Keros Therapeutics Market Cap
Keros Therapeutics has a market cap or net worth of $423.30 million as of December 5, 2025. Its market cap has decreased by -80.51% in one year.
Market Cap
423.30M
Enterprise Value
-252.74M
1-Year Change
-80.51%
Ranking
Category
Stock Price
$21.69
Market Cap Chart
Since April 8, 2020, Keros Therapeutics's market cap has increased from $385.32M to $423.30M, an increase of 9.86%. That is a compound annual growth rate of 1.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 423.30M | -33.99% |
| Dec 31, 2024 | 641.23M | -46.17% |
| Dec 29, 2023 | 1.19B | -9.94% |
| Dec 30, 2022 | 1.32B | -3.39% |
| Dec 31, 2021 | 1.37B | -16.27% |
| Dec 31, 2020 | 1.64B | 324.32% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |